Comparison of heterotypic protection against influenza a/taiwan/86 (Hlnl) by attenuated and inactivated vaccines to a/chile/83-like viruses

Journal of Infectious Diseases

Volumn 163, Issue 2, 1991, Pages 300-304

  Clover, Richard D ^a,b   Crawford, Steven ^a,b   Paul Glezen, W ^a,b   Taber, Larry H ^a,b   Matson, Christine C ^a,b   Couch, Robert B ^a,b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; PLACEBO; VACCINE; VIRUS VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION RATE; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; VIRUS CHARACTERIZATION; VIRUS ISOLATION;

ADOLESCENT; AGE FACTORS; ANTIBODIES, HETEROPHILE; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; HUMAN; INFLUENZA; INFLUENZA A VIRUS, HUMAN; INFLUENZA VACCINE; SOCIOECONOMIC FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 0026086848     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/163.2.300     Document Type: Article

References (31)

1. Glezen WP, Decker M, Joseph SW, Mercready RG Jr. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis 1987;155:1119-26
2. Barker WH., Excess pneumonia- and influenza-associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 1986;76:761-5
3. Barker WH, Mullooly JP. Impact of epidemic type A influenzain a defined adult population. Am J Epidemiol 1980;112:798-813
4. Barker WH, Mullooly JP. Centers for Disease Control. Influenza- United States, 1987-88 season. MMWR 1988;37:497-503
5. Perrotta DM, Decker M, Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. AmJ Epidemiol 1985;122:468-76
6. Glezen WP. Consideration of the risk of influenza in children and indications for prophylaxis. Rev Infect Dis 1980;2:408-20
7. Glezen WP, Six HR, Frank AL, Taber LH, Perrotta DM, Decker M. Impact of epidemics upon communities and families. In: Kendal AP, Patriarca PA, eds. Options for control of influenza. New York: Allen R Liss, 1986:63-73
8. Fox JP, Cooney MK, Hall CE, Foy HM. Influenza virus infections in Seattle families. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infectionand related illness. Am J Epidemiol 1982;116:228-42
9. Longini IM, Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza.Am J Epidemiol 1982;115:736-51
10. Taber LH, Paredes A, Glezen WP, Couch RB. Infection with influenza and other respiratory viruses of humans. J Clin Microbiol 1977;6: 19-22
11. Frank AL, Taber LH, Glezen WP. Influenza B virus infections in the community and the family: the epidemics of 1976-1977and 1979-1980 in Houston, Texas. Am J EpidemioI1983;118:313-25
12. Glezen WP, Couch RB, Taber LH, et al. Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol 1980;111:13-22
13. Monto AS, Davenport FM, Napier JA, Francis T Jr. Effect of vaccination of a school-age population upon the course of an A2/Hong Kong influenza epidemic. Bull WORLD Health Organ 1969;41:537-42
14. Maassab HF, DeBorde C. Development and characterization of coldadapted viruses as live virus vaccines. Vaccine 1985;3:355-69
15. Wright PF, Okabe N, McKee KT Jr, Maassab HF, Karzon DT. Coldadapted recombinant influenzaA virus vaccines in seronegativeyoung children. J Infect Dis 1982;146:71-9
16. Belshe RB, Van Voris LP, Bartram J, Crookshanks FK. Live attenuated influenza A virus vaccines in children: results of a field trial. J Infect Dis 1984;150:834-40
17. Belshe RB, VanVoris LP. Cold recombinant influenzaA/California/1O/78 (HINl) virus vaccine (CR-37) in seronegative children: infectivity and efficacyagainstinvestigationalchallenge. J InfectDis 1984;149:735-40
18. Feldman S, Wright PF, Webster RG, et al. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus. J Infect Dis 1985;152:1212-8
19. Murphy BR, Nelson DL, Wright PF, Tierney EL, Phelan MA, Chanock RM. Secretory and systemic immunologic response in children infected with live attenuated influenza A virus vaccines. Infect Immun 1982;36:1102-8
20. Clements ML, Murphy BR. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 1985;23:66-72
21. Clements ML, Betts RF, Tierney EL, Murphy BR. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin MicrobioI1986;24:l57-60
22. Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF. Comparison of long-term systemic and secretory antibody responses in children given live attenuated, or inactivated influenza A vaccine. J Med Virol 1985;17:325-35
23. Potter C, Jennings R, Clark A, All M. Interference following dual inoculation with influenza A (H3N2) and (HINl) viruses in ferrets and volunteers. J Med Virol 1983;11:77-86
24. Wright PF, Bhargava M, Johnson PR, Thompson J, Karzon DT. Simultaneous administration of live attenuated influenza A vaccines representing different serotypes. Vaccine 1985;3:305-8
25. Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH. Comparison of live, attenuated HIN1 and H3N2 cold-adapted and Avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. J Infect Dis 1988;158:1209-19
26. Gruber WC, Taber LH, Glezen WP, et al. Live attenuated and inactivated influenza vaccine in school-aged children. Am J Dis Child 1990;144:595-600
27. Gruber WC, Taber LH, Glezen WP, et al. Centers for Disease Control: ACIP. Prevention and control of influenza. MMWR 1986;35:317-31
28. Frank AL, Couch RB, Griffis CA, Baxter BD. Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol 1979;10:32-6
29. Baxter BD, Couch RB, Greenberg SB, Kasel JA. Maintenance ofviability and comparison of identification methods for influenza and other respiratory viruses of humans. J Clin Microbiol 1977;6:19-22
30. Frank AL, Puck J, Hughes BJ, Cate TR. Microneutralization test for influenza A and B parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J Clin MicrobioI1980;12: 426-32
31. Davies JR, Grilli EA. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect 1989;102:325-33